MI-136
CAS No. 1628316-74-4
MI-136( MI 136 | MI136 )
Catalog No. M12427 CAS No. 1628316-74-4
A potent Menin-MLL interaction inhibitor with IC50 of 31 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 93 | In Stock |
|
| 5MG | 85 | In Stock |
|
| 10MG | 143 | In Stock |
|
| 25MG | 278 | In Stock |
|
| 50MG | 461 | In Stock |
|
| 100MG | 714 | In Stock |
|
| 200MG | 995 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMI-136
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent Menin-MLL interaction inhibitor with IC50 of 31 nM.
-
DescriptionA potent Menin-MLL interaction inhibitor with IC50 of 31 nM; demonstrates potent inhibitory activity and strong binding affinity to menin.
-
In VitroMI-136 (0-20) exhibits IC50values of 5.59 μM, 7.15 μM, 5.37 μM and 19.76 μM in LNCaP, VCaP, 22rv1 and PNT2 cells.Cell Proliferation Assay Cell Line:AR positive cell lines such as VCaP, LNCaP and 22RV1.Concentration:0-20 μM.Incubation Time:24 h.Result:Inhibited cell proliferation.
-
In VivoMI-136 exhibits T1/2 of 3.1 h after po administration.MI-136 (40 mg/kg, ip) leads to a significant decrease in the growth of castration-resistant VCaP tumors. Animal Model:VCaP xenografts.Dosage:40 mg/kg.Administration:Intraperitoneal injection, 5 days a week.Result:Led to a significant decrease in the growth of castration-resistant VCaP tumors compared to vehicle controls.
-
SynonymsMI 136 | MI136
-
PathwayChromatin/Epigenetic
-
TargetHMTase
-
RecptorAndrogenReceptor
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1628316-74-4
-
Formula Weight470.5132
-
Molecular FormulaC23H21F3N6S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 31 mg/mL
-
SMILESC1CN(CCC1NC2=C3C=C(SC3=NC=N2)CC(F)(F)F)CC4=CC5=C(C=C4)NC(=C5)C#N
-
Chemical Name1H-Indole-2-carbonitrile, 5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Borkin D, et al. J Med Chem. 2016 Feb 11;59(3):892-913.
2. Borkin D, et al. Cancer Cell. 2015 Apr 13;27(4):589-602.
molnova catalog
related products
-
MMSET-IN-1
MMSET-IN-1 is a potent, selective epigenetic oncogene MMSET (aka NSD2 or WHSC1) inhibitor with Ki/IC50 of 1.6/3.3 uM.
-
EPZ-015866
EPZ-015866 (GSK-591, GSK-3203591) is a potent, selective protein methyltransferase 5 (PRMT5) inhibitor with IC50 of 4 nM.
-
CM-272
CM-272 (CM272)?is a novel potent, selective and reversible dual inhibitor of G9a/DNMTs with IC50 of 8 nM and 382 nM for G9a and DNMT1, respectively.
Cart
sales@molnova.com